ArticleBiomarker research2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.
Arnaud Métois et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBiomarker research2025
Arnaud Métois et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.